Product Code: RP-ID-10079005 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10079005
Market Overview:
Forecast 2018 – 2025 | Molecular Diagnostics Industry By Top Key Players (Abbott Laboratories, Beckman Coulter Inc., Biomérieux SA, Grifols SA) By Type(Introduction, Instruments, Software and Services, Reagents & Kits) and By Technology (Hybridization, Polymerase Chain Reaction (PCR), Microarray) - Global Opportunity and Current Growth Analysis
Global Molecular Diagnostics Industry was valued at USD 6.72 Billion in the year 2017. Global Molecular Diagnostics Industry is further expected to grow at a CAGR of 11. 60% from 2018 to reach USD 16.15 Billion by the year 2025. North America region holds the highest Industry share in 2017. While Asia Pacific region is considered as the fastest growing Industry in the forecasted period. The U.S. is the major Industry in 2017 at country level and it is further anticipated to grow at a steady pace in the next 5 years.
The major Industry players in Molecular Diagnostics Industry are Abbott Laboratories, Beckman Coulter Inc., Biomérieux SA, Grifols SA, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Qiagen Netherlands, Danaher Corporation Lab 21, Agilent Technologies, Trinity Biotech and other 13 companies detailed information is provided in research report . Roche Diagnostics holds major Industry share in molecular diagnostics Industry for better global presence both at production and at an operational level. Growing research and development expenditures to address changing demand of consumers, new product launches in recent years are some of the key Industry drivers. Organic growth strategies adopted by most of Tier 1 and Tier 2 manufacturers in recent years is also providing comprehensive Industry opportunities for the various stakeholder.
SWOT Analysis of Molecular Diagnostics Industry
Strengths
Molecular diagnostics advancements
Growing infectious disease Industry
Weakness
Lack of regulatory standards
Level of required financial investment & lack of technical expertise
Opportunity
Rising importance of diagnostics in improving healthcare quality
Development of emerging Industry for Point of care testing.
Threats
Intense competition and reduced healthcare reimbursement
By type, the Industry is segmented as instruments, software and Services and Reagents & Kits. The Polymerase Chain Reaction (PCR) is likely to hold the top Industry share during the forecast period among all other technology segments. The growth can be attributed to the increasing number of blood donations, rising incidence of infectious diseases, and increasing capacity (disposable income). On the other hand, hospitals & clinical Laboratories for users is expected to grow at the highest CAGR of XXX during the year 2018-2025.
Molecular Diagnostics Industry Overview
By type
Introduction
Instruments
Software and Services
Reagents & Kits
By Technology
Hybridization
Polymerase Chain Reaction (PCR)
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing
Others
By Users
Hospitals
Laboratories
Others
By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Related Reports
Proof of Quality & Reliability
